Chemoinformatic characterization of activity and selectivity switches of antiprotozoal compounds

Future Medicinal Chemistry

Volumn 6, Issue 3, 2014, Pages 281-294

  Aguayo Ortiz, Rodrigo ^a   Pérez Villanueva, Jaime ^b   Hernández Campos, Alicia ^a   Castillo, Rafael ^a   Meurice, Nathalie ^c   Medina Franco, José L ^c  

^a Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; MOLECULAR SCAFFOLD;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CHEMICAL MODEL; CHEMICAL PROCEDURES; CHEMOINFORMATIC; CONTROLLED STUDY; DRUG SELECTIVITY; GIARDIA LAMBLIA; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; TRICHOMONAS VAGINALIS;

ANTIPROTOZOAL AGENTS; BENZIMIDAZOLES; COMPUTER-AIDED DESIGN; DATABASES, PHARMACEUTICAL; DRUG DESIGN; FEMALE; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 84893109925     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.173     Document Type: Article

References (31)

1. Stumpfe D, Bajorath J. Exploring activity cliffs in medicinal chemistry. J. Med. Chem. 55(7), 2932-2942 (2012).
2. Bajorath J. Modeling of activity landscapes for drug discovery. Expert Opin. Drug Discov. 7(6), 463-473 (2012).
3. Medina-Franco JL. Scanning structure-Activity relationships with SAS and related maps: From consensus activity cliffs to selectivity switches. J. Chem. Inf. Model. 52(10), 2485-2493 (2012).
4. Hu X, Hu Y, Vogt M, Stumpfe D et al. MMP-Cliffs: Systematic identification of activity cliffs on the basis of matched molecular pairs. J. Chem. Inf. Model. 52(5), 1138-1145 (2012).
5. Medina-Franco JL, Edwards BS, Pinilla C et al. Rapid scanning structure-Activity relationships in combinatorial data sets: Identification of activity switches. J. Chem. Inf. Model. 53(6), 1475-1485 (2013).
6. Pérez-Villanueva J, Santos R, Hernández-Campos A et al. Structure-Activity relationships of benzimidazole derivatives as antiparasitic agents: Dual activity-difference (DAD) maps. Med. Chem. Comm. 2(1), 44-49 (2011).
7. Medina-Franco JL, Yongye AB, Pérez-Villanueva J et al. Multitarget structure-Activity relationships characterized by activity-difference maps and consensus similarity measure. J. Chem. Inf. Model. 51(9), 2427-2439 (2011).
8. Fennell BJ, Naughton JA, Barlow J et al. Microtubules as antiparasitic drug targets. Expert Opin. Drug Discov. 3(5), 501-518 (2008).
9. Navarrete-Vázquez G, Rojano-Vilchis MDM, Yépez-Mulia L et al. Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H- benzimidazole bioisosteres. Eur. J. Med. Chem. 41(1), 135-141 (2006).
10. Navarrete-Vázquez G, Yépez L, Hernández-Campos A et al. Synthesis and antiparasitic activity of albendazole and mebendazole analogues. Bioorg. Med. Chem. 11(21), 4615-4622 (2003).
11. Andrzejewska M, Yépez-Mulia L, Cedillo-Rivera R et al. Synthesis, antiprotozoal and anticancer activity of substituted 2-Trifluoromethyl-And 2-pentafluoroethylbenzimidazoles. Eur. J. Med. Chem. 37(12), 973-978 (2002).
12. Valdez-Padilla D, Rodríguez-Morales S, Hernández-Campos A et al. Synthesis and antiprotozoal activity of novel 1-methylbenzimidazole derivatives. Bioorg. Med. Chem. 17(4), 1724-1730 (2009).
13. Andrzejewska M, Yepez-Mulia L, Tapia A et al. Synthesis, and antiprotozoal and antibacterial activities of S-substituted 4,6-dibromo-And 4,6-dichloro-2-mercaptobenzimidazoles. Eur. J. Pharm. Sci. 21(2-3), 323-329 (2004).
14. Pérez-Villanueva J, Romo-Mancillas A, Hernández-Campos A et al. Antiprotozoal activity of proton-pump inhibitors. Bioorg. Med. Chem. Lett. 21(24), 7351-7354 (2011).
15. Hernández-Luis F, Hernández-Campos A, Castillo R et al. Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis. Eur. J. Med. Chem. 45(7), 3135-3141 (2010).
16. Pérez-Villanueva J, Hernández-Campos A, Yépez-Mulia L et al. Synthesis and antiprotozoal activity of novel 2-{[2-(1H-imidazol-1-yl) ethyl]sulfanyl}-1H-benzimidazole derivatives. Bioorg. Med. Chem. Lett. 23(14), 4221-4224 (2013).
17. Pérez-Villanueva J, Medina-Franco JL, Méndez-Lucio O et al. CASE plots for the chemotype-based activity and selectivity analysis: A CASE study of cyclooxygenase inhibitors. Chem. Biol. Drug Des. 80(5), 752-762 (2012).
18. Méndez-Lucio O, Pérez-Villanueva J, Castillo R et al. Activity landscape modeling of PPAR ligands with dual-Activity difference maps. Bioorg. Med. Chem. 20(11), 3523-3532 (2012).
19. Medina-Franco JL. Activity cliffs: Facts or artifacts? Chem. Biol. Drug Des. 81(5), 553-556 (2013).
20. Jaccard P. Etude comparative de la distribution florale dans une portion des alpes et des jura. Bull. Soc. Vaud. Sci. Nat. Med. 37, 547-579 (1901).
21. Bender A, Glen RC. Molecular similarity: A key technique in molecular informatics. Org. Biomol. Chem. 2(22), 3204-3218 (2004).
22. Chemical Computing Group Inc. Molecular Operating Environment (MOE) (Version 10). Montreal, Canada (2011).
23. Pérez-Villanueva J, Santos R, Hernández-Campos A et al. Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg. Med. Chem. 18(21), 7380-7391 (2010).
24. Rogers D, Hahn M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50(5), 742-754 (2010).
25. Sastry M, Lowrie JF, Dixon SL et al. Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J. Chem. Inf. Model. 50(5), 771-784 (2010).
26. Agrafiotis DK, Wiener JJM, Skalkin A et al. Single R group polymorphisms (SRPs) and R-cliffs: An intuitive framework for analyzing and visualizing activity cliffs in a single analog series. J. Chem. Inf. Model. 51(5), 1122-1131 (2011).
27. Méndez-Lucio O, Pérez-Villanueva J, Castillo R et al. Identifying activity cliff generators of PPAR ligands using SAS maps. Mol. Inf. 31(11-12), 837-846 (2012).
28. López-Vallejo F, Medina-Franco JL, Hernández-Campos A et al. Molecular modeling of some 1H-benzimidazole derivatives with biological activity against Entamoeba histolytica: A comparative molecular field analysis study. Bioorg. Med. Chem. 15(2), 1117-1126 (2007).
29. Guha R. Exploring uncharted territories: Predicting activity cliffs in structure-Activity landscapes. J. Chem. Inf. Model. 52(8), 2181-2191 (2012).
30. Heikamp K, Hu X, Yan A et al. Prediction of activity cliffs using support vector machines. J. Chem. Inf. Model. 52(9), 2354-2365 (2012).
31. Santos RG, Giulianotti MA, Houghten RA et al. Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities. J. Chem. Inf. Model. 53(10), 2613-2625 (2013).